Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Intrinsic Value
The intrinsic value of one Mayinglong Pharmaceutical Group Co Ltd stock under the Base Case scenario is 35.48 CNY. Compared to the current market price of 28.02 CNY, Mayinglong Pharmaceutical Group Co Ltd is Undervalued by 21%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Mayinglong Pharmaceutical Group Co Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Mayinglong Pharmaceutical Group Co Ltd
Balance Sheet Decomposition
Mayinglong Pharmaceutical Group Co Ltd
Current Assets | 4B |
Cash & Short-Term Investments | 3B |
Receivables | 501.1m |
Other Current Assets | 477.4m |
Non-Current Assets | 1.2B |
Long-Term Investments | 149m |
PP&E | 773.5m |
Intangibles | 225.4m |
Other Non-Current Assets | 59m |
Free Cash Flow Analysis
Mayinglong Pharmaceutical Group Co Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Mayinglong Pharmaceutical Group Co Ltd
Revenue
|
3.7B
CNY
|
Cost of Revenue
|
-2B
CNY
|
Gross Profit
|
1.7B
CNY
|
Operating Expenses
|
-1.1B
CNY
|
Operating Income
|
606.7m
CNY
|
Other Expenses
|
-72.7m
CNY
|
Net Income
|
534m
CNY
|
Profitability Score
Profitability Due Diligence
Mayinglong Pharmaceutical Group Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Mayinglong Pharmaceutical Group Co Ltd's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Mayinglong Pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Mayinglong Pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Mayinglong Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Mayinglong Pharmaceutical Group Co Ltd is 38.63 CNY with a low forecast of 37.62 CNY and a high forecast of 40.43 CNY.
Dividends
Current shareholder yield for Mayinglong Pharmaceutical Group Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Mayinglong Pharmaceutical Group Co Ltd stock under the Base Case scenario is 35.48 CNY.
Compared to the current market price of 28.02 CNY, Mayinglong Pharmaceutical Group Co Ltd is Undervalued by 21%.